Medtronic, Inc. (MDT) Reports In-Line Q3 EPS of 84c; Reaffirms FY12 Sales Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $79.27 -0.09%
Revenue Growth %: +11.2%
Financial Fact:
Cash dividends declared per common share: 0.31
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.2%
Financial Fact:
Cash dividends declared per common share: 0.31
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q3 EPS of $0.84, in-line with the analyst estimate of $0.84. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $3.99 billion.
Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
